T. Aronsson et al., The impact of generic drug competition on brand name market shares - Evidence from micro data, REV IND ORG, 19(4), 2001, pp. 425-435
This paper analyses how market shares for brand name drugs are affected by
generic competition. The analysis is based on micro data for twelve differe
nt original drugs, which are all subject to generic competition. For five o
f these drugs, we find that the price of the original relative to the avera
ge price of the generic substitutes significantly affects the market share
of the original drug. In addition, the introduction of a so called "referen
ce price'' system appears to have had a significant impact on the market sh
ares of five original drugs.